Search

Your search keyword '"Al-Kassou, Baravan"' showing total 237 results
Start Over Author "Al-Kassou, Baravan"
237 results on '"Al-Kassou, Baravan"'

13. Distinct Genetic Risk Profile in Aortic Stenosis Compared With Coronary Artery Disease.

Author

Trenkwalder, Teresa, Maj, Carlo, Al-Kassou, Baravan, Debiec, Radoslaw, Doppler, Stefanie A., Musameh, Muntaser D., Nelson, Christopher P., Dasmeh, Pouria, Grover, Sandeep, Knoll, Katharina, Naamanka, Joonas, Mordi, Ify R., Braund, Peter S., Dreßen, Martina, Lahm, Harald, Wirth, Felix, Baldus, Stephan, Kelm, Malte, von Scheidt, Moritz, and Krefting, Johannes

Published
2025
Full Text
View/download PDF

14. C-Reactive Protein to Albumin Ratio in Patients Undergoing Transcatheter Aortic Valve Replacement

Author

Seoudy, Hatim, Shamekhi, Jasmin, Voigtländer, Lisa, Ludwig, Sebastian, Frank, Johanne, Kujat, Tim, Bramlage, Peter, Al-Kassou, Baravan, Sugiura, Atsushi, Rangrez, Ashraf Yusuf, Schofer, Niklas, Puehler, Thomas, Lutter, Georg, Seiffert, Moritz, Nickenig, Georg, Conradi, Lenard, Frey, Norbert, Westermann, Dirk, Sinning, Jan-Malte, and Frank, Derk

Published
2022
Full Text
View/download PDF

20. Quantitative Assessment of Acute Regurgitation Following TAVR: A Multicenter Pooled Analysis of 2,258 Valves

Author

Modolo, Rodrigo, Chang, Chun Chin, Abdelghani, Mohammad, Kawashima, Hideyuki, Ono, Masafumi, Tateishi, Hiroki, Miyazaki, Yosuke, Pighi, Michele, Wykrzykowska, Joanna J., de Winter, Robbert J., Ruck, Andreas, Chieffo, Alaide, van Mourik, Martijn S., Yamaji, Kyohei, Richardt, Gert, de Brito, Fabio S., Jr., Lemos, Pedro A., Al-Kassou, Baravan, Piazza, Nicolo, Tchetche, Didier, Sinning, Jan-Malte, Abdel-Wahab, Mohamed, Soliman, Osama, Søndergaard, Lars, Mylotte, Darren, Onuma, Yoshinobu, Van Mieghem, Nicolas M., and Serruys, Patrick W.

Published
2020
Full Text
View/download PDF

21. Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients

Author

Wolff, Georg, Shamekhi, Jasmin, Al-Kassou, Baravan, Tabata, Noriaki, Parco, Claudio, Klein, Kathrin, Maier, Oliver, Sedaghat, Alexander, Polzin, Amin, Sugiura, Atsushi, Jung, Christian, Grube, Eberhard, Westenfeld, Ralf, Icks, Andrea, Zeus, Tobias, Sinning, Jan-Malte, Baldus, Stephan, Nickenig, Georg, Kelm, Malte, and Veulemans, Verena

Published
2021
Full Text
View/download PDF

22. Impact of Measured and Predicted Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement

Author

Guthoff, Henning, Abdel-Wahab, Mohamed, Kim, Won Keun, Witberg, Guy, Wienemann, Hendrik, Thurow, Maria, Shamekhi, Jasmin, Eckel, Clemens, von der Heide, Ina, Veulemans, Verena, Landt, Martin, Barbanti, Marco, Finkelstein, Ariel, Schewel, Jury, Van Mieghem, Nicolas, Adrichem, Rik, Toggweiler, Stefan, Rheude, Tobias, Nombela-Franco, Luis, Amat-Santos, Ignacio J., Ruile, Philipp, Estévez-Loureiro, Rodrigo, Bunc, Matjaz, Branca, Luca, De Backer, Ole, Tarantini, Giuseppe, Mylotte, Darren, Arzamendi, Dabit, Pauly, Markus, Bleiziffer, Sabine, Renker, Matthias, Al-Kassou, Baravan, Möllmann, Helge, Ludwig, Sebastian, Zeus, Tobias, Tamburino, Corrado, Schmidt, Tobias, Rück, Andreas, von Stein, Philipp, Thiele, Holger, Abdelhafez, Ahmed, Adam, Matti, Baldus, Stephan, Rudolph, Tanja, Mauri, Victor, Guthoff, Henning, Abdel-Wahab, Mohamed, Kim, Won Keun, Witberg, Guy, Wienemann, Hendrik, Thurow, Maria, Shamekhi, Jasmin, Eckel, Clemens, von der Heide, Ina, Veulemans, Verena, Landt, Martin, Barbanti, Marco, Finkelstein, Ariel, Schewel, Jury, Van Mieghem, Nicolas, Adrichem, Rik, Toggweiler, Stefan, Rheude, Tobias, Nombela-Franco, Luis, Amat-Santos, Ignacio J., Ruile, Philipp, Estévez-Loureiro, Rodrigo, Bunc, Matjaz, Branca, Luca, De Backer, Ole, Tarantini, Giuseppe, Mylotte, Darren, Arzamendi, Dabit, Pauly, Markus, Bleiziffer, Sabine, Renker, Matthias, Al-Kassou, Baravan, Möllmann, Helge, Ludwig, Sebastian, Zeus, Tobias, Tamburino, Corrado, Schmidt, Tobias, Rück, Andreas, von Stein, Philipp, Thiele, Holger, Abdelhafez, Ahmed, Adam, Matti, Baldus, Stephan, Rudolph, Tanja, and Mauri, Victor

Abstract

Background: Prosthesis-patient mismatch after transcatheter aortic valve replacement (TAVR) can be measured echocardiographically (measured prosthesis-patient mismatch [PPMm]) or predicted (predicted prosthesis-patient mismatch [PPMp]) using published effective orifice area (EOA) reference values. However, the clinical implications of PPM post-TAVR remain unclear. Objectives: This study aimed to elucidate the prevalence of PPMm and PPMp post-TAVR and their impact on mortality in a large international cohort. Methods: The IMPPACT TAVR (Impact of Measured or Predicted Prosthesis-pAtient mismatCh after TAVR) registry included 38,808 TAVR patients from 26 international centers. Valve Academic Research Consortium 3 criteria were used to define prosthesis-patient mismatch severity. EOA was determined echocardiographically (PPMm) or predicted (PPMp) based on core lab–derived EOA reference values. The primary endpoint was 2-year all-cause mortality. Results: The prevalence of PPMp (moderate: 6.8%, severe: 0.6%) was significantly lower than that of PPMm (moderate: 20.7%, severe: 4.3%; P < 0.001) with negligible correlation between the 2 methods (Kendall's tau c correlation coefficient: 0.063; P < 0.001). In unadjusted analyses, severe PPMm adversely influenced 2-year survival (HR: 1.22; 95% CI: 1.02-1.45; P = 0.027), whereas severe PPMp was not associated with outcomes (HR: 0.81; 95% CI: 0.55-1.19; P = 0.291). After adjusting for confounders, neither PPMm nor PPMp had a significant effect on 2-year all-cause mortality. Conclusions: PPMm and PPMp were associated with different patient characteristics, with PPMm tending toward worse (especially low flow) and PPMp toward better (especially women) survival. After adjusting for confounders, neither PPMm nor PPMp significantly affected 2-year all-cause mortality. Hence, valve selection should not solely be based on hemodynami

Published
2024

27. Cholesterol Crystal Dissolution Rate of Serum Predicts Outcomes in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Author

Al‐Kassou, Baravan, primary, Al‐Kassou, Lara, additional, Mahn, Thorsten, additional, Lütjohann, Dieter, additional, Shamekhi, Jasmin, additional, Willemsen, Nicola, additional, Niepmann, Sven Thomas, additional, Baldus, Stephan, additional, Kelm, Malte, additional, Nickenig, Georg, additional, Latz, Eicke, additional, and Zimmer, Sebastian, additional

Published
2024
Full Text
View/download PDF

32. Impact of transradial versus transfemoral access for preprocedural coronary angiography on TAVR-associated complications

Author

Al-Kassou, Baravan, primary, Al-Shaikh, Hasanin, additional, Aksoy, Adem, additional, Shamekhi, Jasmin, additional, Zietzer, Andreas, additional, Sugiura, Atsushi, additional, Veulemans, Verena, additional, Adam, Matti, additional, Grube, Eberhard, additional, Bakhtiary, Farhad, additional, Zimmer, Sebastian, additional, Kelm, Malte, additional, Baldus, Stephan, additional, Nickenig, Georg, additional, and Sedaghat, Alexander, additional

Published
2023
Full Text
View/download PDF

34. Optimal protamine-to-heparin dosing ratio for the prevention of bleeding complications in patients undergoing TAVR-A multicenter experience

Author

Al-Kassou, Baravan, Veulemans, Verena, Shamekhi, Jasmin, Maier, Oliver, Piayda, Kerstin, Zeus, Tobias, Aksoy, Adem, Zietzer, Andreas, Meertens, Max, Mauri, Victor, Weber, Marcel, Sinning, Jan-Malte, Grube, Eberhard, Adam, Matti, Bakhtiary, Farhad, Zimmer, Sebastian, Baldus, Stephan, Kelm, Malte, Nickenig, Georg, Sedaghat, Alexander, Al-Kassou, Baravan, Veulemans, Verena, Shamekhi, Jasmin, Maier, Oliver, Piayda, Kerstin, Zeus, Tobias, Aksoy, Adem, Zietzer, Andreas, Meertens, Max, Mauri, Victor, Weber, Marcel, Sinning, Jan-Malte, Grube, Eberhard, Adam, Matti, Bakhtiary, Farhad, Zimmer, Sebastian, Baldus, Stephan, Kelm, Malte, Nickenig, Georg, and Sedaghat, Alexander

Abstract

Background Despite major advances, transcatheter aortic valve replacement (TAVR) is still associated with procedure-specific complications. Although previous studies reported lower bleeding rates in patients receiving protamine for heparin reversal, the optimal protamine-to-heparin dosing ratio is unknown. Hypothesis The aim of this study was a comparison of two different heparin antagonization regimens for the prevention of bleeding complications after TAVR. Methods The study included 1446 patients undergoing TAVR, of whom 623 received partial and 823 full heparin antagonization. The primary endpoint was a composite of 30-day mortality, life-threatening, and major bleeding. Safety endpoints included stroke and myocardial infarction at 30 days. Results Full antagonization of heparin resulted in lower rates of the primary endpoint as compared to partial heparin reversal (5.6% vs. 10.4%, p < .01), which was mainly driven by lower rates of life-threatening (0.5% vs. 1.6%, p = .05) and major bleeding (3.2% vs. 7.5%, p < .01). Moreover, the incidence of major vascular complications was significantly lower in patients with full heparin reversal (3.5% vs. 7.5%, p < .01). The need for red-blood-cell transfusion was lower in patients receiving full as compared to partial heparin antagonization (10.4% vs. 15.9%, p < .01). No differences were observed in the incidence of stroke and myocardial infarction between patients with full and partial heparin reversal (2.2% vs. 2.6%, p = .73 and 0.2% vs. 0.4%, p = .64, respectively). Conclusions Full heparin antagonization resulted in significantly lower rates of life-threatening and major bleeding after TAVR as compared to partial heparin reversal. The occurrence of stroke and myocardial infarction was low and comparable between both groups.

Published
2023

35. Impact of different guidewires on the implantation depth using the largest self-expandable TAVI device

Author

Veulemans, Verena, Wilde, Nihal, Wienemann, Hendrik, Adrichem, Rik, Hokken, Thijmen W., Al-Kassou, Baravan, Shamekhi, Jasmin, Mauri, Victor, Maier, Oliver, Jung, Christian, Horn, Patrick, Adam, Matti, Nickenig, Georg, Baldus, Stephan, Van Mieghem, Nicolas M., Kelm, Malte, Sedaghat, Alexander, Zeus, Tobias, Veulemans, Verena, Wilde, Nihal, Wienemann, Hendrik, Adrichem, Rik, Hokken, Thijmen W., Al-Kassou, Baravan, Shamekhi, Jasmin, Mauri, Victor, Maier, Oliver, Jung, Christian, Horn, Patrick, Adam, Matti, Nickenig, Georg, Baldus, Stephan, Van Mieghem, Nicolas M., Kelm, Malte, Sedaghat, Alexander, and Zeus, Tobias

Abstract

Background: The deployment process of the largest self-expandable device (STHV-34) during transcatheter aortic valve implantation (TAVI) might be challenging due to stabilization issues. Whether the use of different TAVI-guidewires impact the procedural success and outcome is not well-known. Therefore, we sought to evaluate the impact of non-Lunderquist (NLu) vs. the Lunderquist (Lu) guidewires during TAVI using the STHV-34 on the procedural and 30-day outcomes. Methods: The primary study endpoint was defined as the final implantation depth (ID) depending on the selected guidewire strategy. Key secondary endpoints included VARC-3-defined complications. Results: The study cohort included 398 patients of four tertiary care institutions, of whom 79.6% (317/398) had undergone TAVI using NLu and 20.4% (81/398) using Lu guidewires. Baseline characteristics did not substantially differ between NLu and Lu patients. The average ID was higher in the Lu cohort (NLu vs. Lu: −5.2 [−7.0–(−3.5)] vs. −4.5 [−6.0–(−3.0)]; p = 0.022*). The optimal ID was reached in 45.0% of patients according to former and only in 20.1% according to nowadays best practice recommendations. There was no impact of the guidewire use on the 30-day outcomes, including conduction disturbances and pacemaker need (NLu vs. Lu: 15.1 vs. 18.5%; p = 0.706). Conclusion: The use of the LunderquistTM guidewire was associated with a higher ID during TAVI with the STHV-34 without measurable benefits in the 30-day course concerning conduction disturbances and associated pacemaker need. Whether using different guidewires might impact the outcome in challenging anatomies should be further investigated in randomized studies under standardized conditions.

Published
2023

36. Elucidation of the genetic causes of bicuspid aortic valve disease

Author

Gehlen, Jan, Stundl, Anja, Debiec, Radoslaw, Fontana, Federica, Krane, Markus, Sharipova, Dinara, Nelson, Christopher P., Al-Kassou, Baravan, Giel, Ann Sophie, Sinning, Jan Malte, Bruenger, Christopher M. H., Zelck, Carolin F., Koebbe, Laura L., Braund, Peter S., Webb, Thomas R., Hetherington, Simon, Ensminger, Stephan, Fujita, Buntaro, Mohamed, Salah A., Shrestha, Malakh, Krueger, Heike, Siepe, Matthias, Kari, Fabian Alexander, Nordbeck, Peter, Buravezky, Larissa, Kelm, Malte, Veulemans, Verena, Adam, Matti, Baldus, Stephan, Laugwitz, Karl Ludwig, Haas, Yannick, Karck, Matthias, Mehlhorn, Uwe, Conzelmann, Lars Oliver, Breitenbach, Ingo, Lebherz, Corinna, Urbanski, Paul, Kim, Won Keun, Kandels, Joscha, Ellinghaus, David, Nowak-Goettl, Ulrike, Hoffmann, Per, Wirth, Felix, Doppler, Stefanie, Lahm, Harald, Dressen, Martina, von Scheidt, Moritz, Knoll, Katharina, Kessler, Thorsten, Hengstenberg, Christian, Schunkert, Heribert, Nickenig, Georg, Noethen, Markus M., Bolger, Aidan P., Abdelilah-Seyfried, Salim, Samani, Nilesh J., Erdmann, Jeanette, Trenkwalder, Teresa, Schumacher, Johannes, Gehlen, Jan, Stundl, Anja, Debiec, Radoslaw, Fontana, Federica, Krane, Markus, Sharipova, Dinara, Nelson, Christopher P., Al-Kassou, Baravan, Giel, Ann Sophie, Sinning, Jan Malte, Bruenger, Christopher M. H., Zelck, Carolin F., Koebbe, Laura L., Braund, Peter S., Webb, Thomas R., Hetherington, Simon, Ensminger, Stephan, Fujita, Buntaro, Mohamed, Salah A., Shrestha, Malakh, Krueger, Heike, Siepe, Matthias, Kari, Fabian Alexander, Nordbeck, Peter, Buravezky, Larissa, Kelm, Malte, Veulemans, Verena, Adam, Matti, Baldus, Stephan, Laugwitz, Karl Ludwig, Haas, Yannick, Karck, Matthias, Mehlhorn, Uwe, Conzelmann, Lars Oliver, Breitenbach, Ingo, Lebherz, Corinna, Urbanski, Paul, Kim, Won Keun, Kandels, Joscha, Ellinghaus, David, Nowak-Goettl, Ulrike, Hoffmann, Per, Wirth, Felix, Doppler, Stefanie, Lahm, Harald, Dressen, Martina, von Scheidt, Moritz, Knoll, Katharina, Kessler, Thorsten, Hengstenberg, Christian, Schunkert, Heribert, Nickenig, Georg, Noethen, Markus M., Bolger, Aidan P., Abdelilah-Seyfried, Salim, Samani, Nilesh J., Erdmann, Jeanette, Trenkwalder, Teresa, and Schumacher, Johannes

Abstract

Aims The present study aims to characterize the genetic risk architecture of bicuspid aortic valve (BAV) disease, the most common congenital heart defect. Methods and results We carried out a genome-wide association study (GWAS) including 2236 BAV patients and 11 604 controls. This led to the identification of a new risk locus for BAV on chromosome 3q29. The single nucleotide polymorphism rs2550262 was genome-wide significant BAV associated (P = 3.49 x 10(-08)) and was replicated in an independent case-control sample. The risk locus encodes a deleterious missense variant in MUC4 (p.Ala4821Ser), a gene that is involved in epithelial-to-mesenchymal transformation. Mechanistical studies in zebrafish revealed that loss of Muc4 led to a delay in cardiac valvular development suggesting that loss of MUC4 may also play a role in aortic valve malformation. The GWAS also confirmed previously reported BAV risk loci at PALMD (P = 3.97 x 10(-16)), GATA4 (P = 1.61 x 10(-09)), and TEX41 (P = 7.68 x 10(-04)). In addition, the genetic BAV architecture was examined beyond the single-marker level revealing that a substantial fraction of BAV heritability is polygenic and similar to 20% of the observed heritability can be explained by our GWAS data. Furthermore, we used the largest human single-cell atlas for foetal gene expression and show that the transcriptome profile in endothelial cells is a major source contributing to BAV pathology. Conclusion Our study provides a deeper understanding of the genetic risk architecture of BAV formation on the single marker and polygenic level.

Published
2023

39. Impact of different guidewires on the implantation depth using the largest self-expandable TAVI device

Author

Veulemans, Verena, primary, Wilde, Nihal, additional, Wienemann, Hendrik, additional, Adrichem, Rik, additional, Hokken, Thijmen W., additional, Al-Kassou, Baravan, additional, Shamekhi, Jasmin, additional, Mauri, Victor, additional, Maier, Oliver, additional, Jung, Christian, additional, Horn, Patrick, additional, Adam, Matti, additional, Nickenig, Georg, additional, Baldus, Stephan, additional, Van Mieghem, Nicolas M., additional, Kelm, Malte, additional, Sedaghat, Alexander, additional, and Zeus, Tobias, additional

Published
2023
Full Text
View/download PDF

41. Echocardiographic progression of calcific aortic valve disease in patients with preexisting aortic valve sclerosis

Author

Shamekhi, Jasmin, primary, Uehre, Carina, additional, Al-Kassou, Baravan, additional, Weber, Marcel, additional, Sedaghat, Alexander, additional, Sugiura, Atsushi, additional, Wilde, Nihal, additional, Adam, Matti, additional, Veulemans, Verena, additional, Kelm, Malte, additional, Baldus, Stephan, additional, Nickenig, Georg, additional, and Zimmer, Sebastian, additional

Published
2022
Full Text
View/download PDF

42. Transcatheter aortic valve implantation with different self-expanding devices—a propensity score-matched multicenter comparison

Author

Wienemann, Hendrik, primary, Hof, Alexander, additional, Ludwig, Sebastian, additional, Veulemans, Verena, additional, Sedaghat, Alexander, additional, Iliadis, Christos, additional, Meertens, Max, additional, Macherey, Sascha, additional, Hohmann, Christopher, additional, Kuhn, Elmar, additional, Al-Kassou, Baravan, additional, Wilde, Nihal, additional, Schofer, Niklas, additional, Bleiziffer, Sabine, additional, Maier, Oliver, additional, Kelm, Malte, additional, Baldus, Stephan, additional, Rudolph, Tanja Katharina, additional, Adam, Matti, additional, and Mauri, Victor, additional

Published
2022
Full Text
View/download PDF

43. The lncRNA MRPL20-AS1 is associated with severe OSAS and downregulated upon hypoxic injury of endothelial cells

Author

Zietzer, Andreas, primary, Breitrück, Nils, additional, Düsing, Philip, additional, Böhle, Sabrina, additional, Klussmann, Jens Peter, additional, Al-Kassou, Baravan, additional, Goody, Philip Roger, additional, Hosen, Mohammed Rabiul, additional, Nickenig, Georg, additional, Nachtsheim, Lisa, additional, Shabli, Sami, additional, Jansen, Felix, additional, and Jansen, Stefanie, additional

Published
2022
Full Text
View/download PDF

44. Echocardiographic Progression of Calcific Aortic Valve Disease in Patients with Preexisting Aortic Valve Sclerosis.

Author

Shamekhi, Jasmin, Uehre, Carina, Al-Kassou, Baravan, Weber, Marcel, Sugiura, Atsushi, Wilde, Nihal, Mauri, Victor, Veulemans, Verena, Kelm, Malte, Baldus, Stephan, Nickenig, Georg, and Zimmer, Sebastian

Abstract

Background: We aimed to evaluate echocardiographic parameters to predict calcific aortic valve disease (CAVD) progression. CAVD ranges from aortic valve sclerosis (ASc) with no functional impairment of the aortic valve to severe aortic stenosis (AS). It remains uncertain, which patients with ASc have a particularly high risk of developing AS. Methods: We included a total of 153 patients with visual signs of ASc and peak flow velocity (Vmax) below 2.5 m/s at baseline echocardiography. Progression of CAVD to AS was defined as an increase in Vmax ≥2.5 m/s with a delta of ≥0.1 m/s; stable ASc was defined as Vmax below 2.5 m/s and a delta <0.1 m/s. Finally, we compared clinical and echocardiographic parameters between these two groups. Results: The mean age at baseline was 73.5 (± 8.2) years and 66.7% were of male sex. After a mean follow-up of 1463 days, 57 patients developed AS, while 96 patients remained in the ASc group. The AS group showed significantly more calcification (p < 0.001) and thickening (p < 0.001) of the aortic valve cusps at baseline, although hemodynamics showed no evidence of AS in both groups (ASc group: Vmax 1.6 ± 0.3 m/s versus AS group: Vmax 1.9 ± 0.3 m/s; p < 0.001). Advanced calcification (odds ratio [OR]: 4.8, 95% confidence interval [CI]: 1.5–15.9; p = 0.009) and a cusp thickness >0.26 cm (OR: 16.6, 95% CI: 5.4–50.7; p < 0.001) were independent predictors for the development of AS. Conclusions: The acquisition of simple echocardiographic parameter may help to identify patients with particularly high risk of developing AS. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

45. Optimal protamine‐to‐heparin dosing ratio for the prevention of bleeding complications in patients undergoing TAVR—A multicenter experience

Author

Al‐Kassou, Baravan, primary, Veulemans, Verena, additional, Shamekhi, Jasmin, additional, Maier, Oliver, additional, Piayda, Kerstin, additional, Zeus, Tobias, additional, Aksoy, Adem, additional, Zietzer, Andreas, additional, Meertens, Max, additional, Mauri, Victor, additional, Weber, Marcel, additional, Sinning, Jan‐Malte, additional, Grube, Eberhard, additional, Adam, Matti, additional, Bakhtiary, Farhad, additional, Zimmer, Sebastian, additional, Baldus, Stephan, additional, Kelm, Malte, additional, Nickenig, Georg, additional, and Sedaghat, Alexander, additional

Published
2022
Full Text
View/download PDF

46. Mortality prediction of the frailty syndrome in patients with severe mitral regurgitation

Author

Shamekhi, Jasmin, primary, Al-Kassou, Baravan, additional, Weber, Marcel, additional, Goody, Philip Roger, additional, Zimmer, Sebastian, additional, Germeroth, Jana, additional, Gillrath, Jana, additional, Feldmann, Katharina, additional, Lohde, Luisa, additional, Sedaghat, Alexander, additional, Nickenig, Georg, additional, and Sinning, Jan-Malte, additional

Published
2022
Full Text
View/download PDF

47. A simplified cardiac damage staging predicts the outcome of patients undergoing TAVR—A multicenter analysis

Author

Shamekhi, Jasmin, primary, Hasse, Caroline, additional, Veulemans, Verena, additional, Al‐Kassou, Baravan, additional, Piayda, Kerstin, additional, Maier, Oliver, additional, Zeus, Tobias, additional, Weber, Marcel, additional, Sedaghat, Alexander, additional, Zimmer, Sebastian, additional, Kelm, Malte, additional, Nickenig, Georg, additional, and Sinning, Jan‐Malte, additional

Published
2022
Full Text
View/download PDF

48. Outcomes of Redo Transcatheter Aortic Valve Replacement According to the Initial and Subsequent Valve Type

Author

Landes, Uri, primary, Richter, Ilan, additional, Danenberg, Haim, additional, Kornowski, Ran, additional, Sathananthan, Janarthanan, additional, De Backer, Ole, additional, Søndergaard, Lars, additional, Abdel-Wahab, Mohamed, additional, Yoon, Sung-Han, additional, Makkar, Raj R., additional, Thiele, Holger, additional, Kim, Won-Keun, additional, Hamm, Christian, additional, Buzzatti, Nicola, additional, Montorfano, Matteo, additional, Ludwig, Sebastian, additional, Schofer, Niklas, additional, Voigtlaender, Lisa, additional, Guerrero, Mayra, additional, El Sabbagh, Abdallah, additional, Rodés-Cabau, Josep, additional, Mesnier, Jules, additional, Okuno, Taishi, additional, Pilgrim, Thomas, additional, Fiorina, Claudia, additional, Colombo, Antonio, additional, Mangieri, Antonio, additional, Eltchaninoff, Helene, additional, Nombela-Franco, Luis, additional, Van Wiechen, Maarten P.H., additional, Van Mieghem, Nicolas M., additional, Tchétché, Didier, additional, Schoels, Wolfgang H., additional, Kullmer, Matthias, additional, Barbanti, Marco, additional, Tamburino, Corrado, additional, Sinning, Jan-Malte, additional, Al-Kassou, Baravan, additional, Perlman, Gidon Y., additional, Ielasi, Alfonso, additional, Fraccaro, Chiara, additional, Tarantini, Giuseppe, additional, De Marco, Federico, additional, Witberg, Guy, additional, Redwood, Simon R., additional, Lisko, John C., additional, Babaliaros, Vasilis C., additional, Laine, Mika, additional, Nerla, Roberto, additional, Finkelstein, Ariel, additional, Eitan, Amnon, additional, Jaffe, Ronen, additional, Ruile, Philipp, additional, Neumann, Franz J., additional, Piazza, Nicolo, additional, Sievert, Horst, additional, Sievert, Kolja, additional, Russo, Marco, additional, Andreas, Martin, additional, Bunc, Matjaz, additional, Latib, Azeem, additional, Bruoha, Sharon, additional, Godfrey, Rebecca, additional, Hildick-Smith, David, additional, Barbash, Israel, additional, Segev, Amit, additional, Maurovich-Horvat, Pál, additional, Szilveszter, Balint, additional, Spargias, Konstantinos, additional, Aravadinos, Dionisis, additional, Nazif, Tamim M., additional, Leon, Martin B., additional, and Webb, John G., additional

Published
2022
Full Text
View/download PDF

49. Optimal Protamine-to-Heparin Dosing Ratio for the Prevention of Bleeding Complications in Patients Undergoing TAVR – A Multicenter Experience

Author

Al-Kassou, Baravan, primary, Piayda, Kerstin, additional, Zeus, Tobias, additional, Aksoy, Adem, additional, Shamekhi, Jasmin, additional, Zietzer, Andreas, additional, Grube, Eberhard, additional, Zimmer, Sebastian, additional, Sinning, Jan-Malte, additional, Kelm, Malte, additional, Nickenig, Georg, additional, Veulemans, Verena, additional, and Sedaghat, Alexander, additional

Published
2022
Full Text
View/download PDF

50. Longer leukocyte telomere length is associated with myeloid inflammation and increased mortality after transcatheter aortic valve replacement

Author

Hoffmann, Jedrzej, primary, Tabata, Noriaki, additional, Mas-Peiro, Silvia, additional, Spyridopoulos, Ioakim, additional, Sinning, Jan-Malte, additional, Berkowitsch, Alexander, additional, Martin-Ruiz, Carmen, additional, Al-Kassou, Baravan, additional, Herrmann, Eva, additional, Dimmeler, Stefanie, additional, Zeiher, Andreas M, additional, and Vasa-Nicotera, Mariuca, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results